drugset / Trial / NCT04417049
Treatment of Bipolar Depression With Pentoxifylline
NaSingle-groupOpen-labelTreatment
Summary
Growing theoretical and clinical evidence has suggested that pentoxifylline may have an effect in improving depressive symptoms. Herein, we aim to evaluate the effect of pentoxifylline in patients with bipolar depression over an 8-week trial.
Timeline
- Start
- 2021-07-12
- Primary completion
- 2021-11-03
- Completion
- 2021-11-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pentoxifylline | Small molecule | 400 mg | Oral |